VTEM Banners
VTEM Banners
VTEM Banners
VTEM Banners

Study: EpiPens should work at least a while past expiration dates

Is an expired EpiPen better than no EpiPen at all? A recent study by pharmacist F. Lee Cantrell of the California Poison Control Center says definitely yes! After analyzing 40 expired EpiPens, he found that even 50 months past expiration the EpiPens retained 84 percent of epinephrine concentrations - enough to prevent anaphylactic shock. While Mylan is working on producing an EpiPen with a longer shelf life, patients are still encouraged to refill their EpiPen Auto-Injector approximately every 12 to 18 months to be assured of 100% effectiveness.

Hands Holding EpiPen Injector
Photo by Lucas Trieb

Study: EpiPens should work at least a while past expiration dates

Posted by the Reuters News Service on CNBC Web site
May 9th, 2017

It's worth a shot to use an expired EpiPen, if that's all you have, a new study suggests.

For more than four years past their stamped expiration dates, the handheld injectors retained high-enough concentrations of epinephrine to in all likelihood prevent potentially fatal allergic reactions, the study found.

Continue Reading

One Student’s Death Was a Belated “Wake-Up Call”

Chicago Public Schools Logo

How Chicago Public Schools Got Emergency Supplies of Epinephrine Into Every One of Its Buildings

By Katy Smyser, Phil Rogers and Rich Moy
Tuesday, March 7th, 2017

For many children, the first time they suffer a severe allergic reaction to a food is when they’re in school. Chicago-area public schools can keep extra supplies of epinephrine auto-injectors on hand for just these types of emergencies, but NBC5 Investigates has discovered that a surprising number do not.

Continue Reading

Auvi-Q Offers Possible Alternative to Epi-Pen(TM)

Auvi-Q Offers Possible Alternative to Epi-Pen

Various Epinepherine Injectors

By Kristen Stewart
February 6th, 2017

Anyone with severe allergies knows the importance of having an epinephrine auto-injector (EAI) at the ready. However, with the Epi-PenTM jumping more than $500 in price in the last eight years and until recently no other companies having an epinephrine auto-injector device available, not everyone can afford this potentially life-saving medication. That may be about to change as Kaleo’s Auvi-Q re-enters the U.S. market on February 14th.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2017© Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions